We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Applied Biosystems Completes Acquisition of the Research Products Division of Ambion

Read time: Less than a minute

Applied Biosystems Group, and Applera Corporation business, has announced that it has completed the previously announced acquisition of the Research Products Division of Ambion, Inc.

"We are excited about the many opportunities for sales growth and new products that we anticipate as a result of this strategic acquisition," said Catherine M. Burzik, president of Applied Biosystems.

"We welcome Ambion's employees and anticipate a smooth integration of product lines and personnel as we accelerate the delivery of more complete workflow solutions to our global customer base."

The research and development, manufacturing, and other operations of Ambions Research Products Division will continue to be based in Austin, Texas and its approximately 300 employees will be integrated into the Applied Biosystems global workforce of approximately 4,000 employees.

Ambion will become a center of excellence within the Molecular Biology Divisions consumables business with a focus on expanding the range of consumables products in the Applied Biosystems portfolio.

Recent Ambion product introductions include reagents associated with microRNA and RNA interference.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.